Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Helping healthcare professionals to support patients
RSV: The risk for adults aged 60 and over
This is a promotional webinar organised and funded by GSK for Healthcare professionals and other relevant decision makers only.
Adverse event reporting statement is at the foot of this page.
Join our expert-led webinars on 18th April where we will be discussing the risks of respiratory syncytial virus (RSV) for adults aged 60 and over and how to help defend against RSV through vaccination.
Prescribing Information GB & NI
March 2024 | PM-GB-SGX-WCNT-240017 (V1.0)
Quick links
Webinars & events
Featured products
Links to prescribing information at bottom of page.
More resources
Get more from GSKpro
Get access to free patient resources including demo devices, exclusive webinars on the topics that matter to you and more.
Prescribing information
Trelegy Ellipta prescribing information
Nucala prescribing information
Zejula prescribing information (GB)
Zejula prescribing information (NI)
SHINGRIX prescribing information (GB)
SHINGRIX prescribing information (NI)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.
April 2024 | PM-GB-NA-WCNT-210014 (V8.0)
